Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Ben Robbins

Venture Capital Massachusetts, United States ·Founded 2014

Overview

Ben Robbins is a General Partner at GV, investing across healthcare delivery and neuropsychiatric therapeutics. As a psychiatrist by background, he also leads GV’s investments in mental health-related companies, including Firsthand and Guidelight. His investments include Aspire (acquired by Anthem), Rodin (acquired by Alkermes), Carebridge, Patina, Waltz Health, Nym, and Cerevance. Ben joined GV as a venture partner in 2014 and was named general partner in 2022. He completed psychiatric training at Massachusetts General Hospital and McLean Hospital, the top and second-ranked departments of psychiatry in the United States. He also co-founded a non-profit to fund, build, and operate a primary school for AIDS orphans in Tanzania. Ben received his M.D. from Harvard Medical School, MBA from Harvard Business School, and B.A. with honors from Dartmouth College, where he was a member of the football team.

Investment Focus

Focus on healthcare delivery and neuropsychiatric therapeutics
Interest in mental health-related companies
Preference for early-stage investments in the United States

Portfolio Companies

NymAspire HealthRodin TherapeuticsFirsthandWaltz HealthCerevanceCareBridgePatinaGuidelight

Reach Ben Robbins directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Ben Robbins

What sectors does Ben Robbins invest in?

Ben Robbins invests in Technology, Healthcare, FinTech, SaaS, Artificial Intelligence and Healthcare Services, and is based in Massachusetts, United States. Ben Robbins is listed as a venture capital in the ConnectSafely investor database.